Hear more about Buffett's one and only Tech holding, join our Conference Call at 2pm CT Wednesday July 23rd. HIDE

Neurocrine Biosciences (NBIX)

Add to Watchlists Create an Alert
13.50 +0.33  +2.51% NASDAQ Jul 22, 1:38PM BATS Real time Currency in USD
View Full Chart
NBIX Price Chart
View All Events

NBIX Events

Date Type Description
05/22/2014 Misc Annual General Meeting for Neurocrine Biosciences Inc
04/30/2014 17:00 EDT Misc Neurocrine Biosciences Inc 1Q2014 Earning Conference Call
04/30/2014 Earnings Neurocrine Biosciences Inc 1Q2014 Earning Result. Estimate: -0.19.
02/06/2014 17:00 EDT Misc Neurocrine Biosciences, Inc. 4Q2013 Earning Conference Call
02/06/2014 Earnings Neurocrine Biosciences, Inc. 4Q2013 Earning Result. Estimate: -0.17.
10/29/2013 17:00 EDT Misc Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2013 Financial Results Conference Call
10/29/2013 Earnings Neurocrine Biosciences Reports Third Quarter 2013 Results. Estimate: -0.20.
07/25/2013 17:00 EDT Misc Q2 2013 Neurocrine Biosciences Earnings Conference Call
07/25/2013 Earnings Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2013 Financial Results. Estimate: -0.20.
View All Performance Charts

NBIX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Neurocrine Biosciences is down 7.22% over the last year vs S&P 500 Total Return up 19.76%, H Lundbeck up 16.90%, and Acura Pharmaceuticals down 47.42%.

Get Quote for

PDF Report for NBIX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NBIX Pro Report PDF

Portfolio Strategies Featuring NBIX

Did Neurocrine Biosciences make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NBIX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Company Website: http://www.neurocrine.com
  • IR Website: http://www.neurocrine.com/index.cfm?navid=6
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Neurocrine Biosciences, Inc., discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders.

NBIX Excel Add-In Codes

  • Name: =YCI("NBIX","name")
  • Description: =YCI("NBIX","description")
  • Sector: =YCI("NBIX","sector")
  • Industry: =YCI("NBIX","industry")
  • Est. Current Fiscal Year End: =YCI("NBIX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.